Inspire Medical Systems (INSP) Earnings Analysis
Inspire Medical Systems (INSP) next reports earnings on 2026-08-03, consensus EPS -0.22 USD. Last quarter (2026-05-04) it beat with EPS 0.1 USD vs -0.27533 USD est (+136.3%). It has beaten estimates in 6/6 recent quarters (100%). Trailing P/E 11.13.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does INSP next report earnings?
| Next earnings date | 2026-08-03 |
|---|---|
| Consensus EPS estimate | -0.22 USD |
| Revenue estimate | 0.19B |
INSP earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2026-05-04 | 0.1 USD | -0.27533 USD | +136.3% | Beat |
| 2025-11-03 | 0.38 USD | -0.15 USD | +353.3% | Beat |
| 2025-08-04 | 0.45 USD | 0.22 USD | +104.5% | Beat |
| 2025-05-05 | 0.1 USD | -0.23 USD | +143.5% | Beat |
| 2025-02-10 | 1.15 USD | 0.74 USD | +55.4% | Beat |
| 2024-11-04 | 0.6 USD | 0.08 USD | +650% | Beat |
Beat rate: 6/6 (100%) over reported quarters with consensus data.
INSP valuation and analyst view
| Trailing P/E | 11.13 |
|---|---|
| Trailing EPS | 4.569 USD |
| Price / book | 1.83 |
| Dividend yield | 0.00% |
| Market cap | 1.47B |
| Analyst consensus | Hold (10 buy / 17 hold / 0 sell) |
| Avg price target | 48.5 USD |
Related research pages
Frequently asked questions
When is Inspire Medical Systems (INSP)'s next earnings date?
Inspire Medical Systems is next scheduled to report on 2026-08-03, with a consensus EPS estimate of -0.22 USD and revenue estimate of 0.19B.
Did INSP beat earnings last quarter?
In its 2026-05-04 report, INSP posted EPS of 0.1 USD versus a -0.27533 USD estimate — a beat of 136.3%.
What is INSP's earnings track record?
Over the last 6 reported quarters with consensus data, INSP beat estimates 6 times (100%).
What is INSP's current P/E ratio and EPS?
INSP trades at a trailing P/E of 11.13 on trailing EPS of 4.569115024899371 USD.
What do analysts rate INSP?
Analyst consensus is "Hold" across 27 ratings (0 strong buy, 10 buy, 17 hold, 0 sell, 0 strong sell). Average 12-month price target: 48.5 USD.